RBM acquired biomarker-related IP for Alzheimer's disease and other central nervous system conditions.
Consumables sales were up 53 percent during the quarter to an all-time high of $15 million.
The firm has received pre-IDE evaluations from the FDA for BreastGeneDx and is currently looking for partners to help it during the next stage of assay validation.
The Prevail patient registry will be used to analyze primary care ambulatory practices for risk factor management of patients who have a high risk of converting to type 2 diabetes.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.